Serial Tuberculosis screening in inflammatory bowel disease patients under anti-TNFα therapy.

about

Serial Tuberculosis screening in inflammatory bowel disease patients under anti-TNFα therapy.

Item

http://www.wikidata.org/entity/Q40176122

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Serial Tuberculosis screening ...... ients under anti-TNFα therapy.

@en

type

Item

label

Serial Tuberculosis screening ...... ients under anti-TNFα therapy.

@en

prefLabel

Serial Tuberculosis screening ...... ients under anti-TNFα therapy.

@en

P1476

Serial Tuberculosis screening ...... ients under anti-TNFα therapy.

@en

P2093

António Sarmento

http://www.w3.org/2001/XMLSchema#string

Cláudia Camila Dias

http://www.w3.org/2001/XMLSchema#string

Fernando Magro

http://www.w3.org/2001/XMLSchema#string

Joana Afonso

http://www.w3.org/2001/XMLSchema#string

Rogério Ruas

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy

Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review

Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion.

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.

Serial testing with the interferon-γ release assay in Portuguese healthcare workers

The Significance of Sensitive Interferon Gamma Release Assays for Diagnosis of Latent Tuberculosis Infection in Patients Receiving Tumor Necrosis Factor-α Antagonist Therapy.

Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis.

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.

The role of interferon-gamma release assays in predicting the emergence of active tuberculosis in the setting of biological treatment: a case report and review of the literature.

Tuberculosis in anti-TNF-α treated patients remains a problem in countries with an intermediate incidence: analysis of 25 patients matched with a control population.

P304

1223-1229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ECCO-JCC/JJX080

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

C Abreu

P577

2017-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28605520

http://www.w3.org/2001/XMLSchema#string